Wikidata

(Q38390490)

English

Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis: Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study

scientific article published on 05 July 2016

In more languages

Statements

title
Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis: Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
27380540
retrieved
2 September 2017
author
author name string
David K B Li
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
27380540
retrieved
2 September 2017
Brian Hunter
series ordinal
10
1 reference
stated in
Europe PubMed Central
PubMed ID
27380540
retrieved
2 September 2017
Sophie Arnould
series ordinal
11
1 reference
stated in
Europe PubMed Central
PubMed ID
27380540
retrieved
2 September 2017
publication date
5 July 2016
1 reference
stated in
Europe PubMed Central
PubMed ID
27380540
retrieved
2 September 2017
page(s)
1089-1098
1 reference
stated in
Europe PubMed Central
PubMed ID
27380540
retrieved
2 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q38390490&oldid=1843640023"